Gilead Sciences did not disclose details about the safety concern that led to an FDA partial clinical hold on five studies evaluating its cancer drug, magrolimab. But this experimental cancer immunotherapy introduces a safety risk that's a known problem for all drugs in this class.
The supply chain needs of the pharmaceutical industry are growing increasingly complex, particularly with the growth of cell and gene therapies that require timely delivery of medication components that have to be kept at stable temperatures.
A new report,Resilience in volatility: Modernizing the supply chainfrom Microsoft highlights factors that have stressed the supply chain over the past 18 months and how companies are responding to this crisis as they lay the groundwork to minimize the impact of global events in the future.
We are extending our INVEST 2022 Pitch Perfect deadline to Feb 11, 11:59 p.m. ET to allow interested startups to apply to the 4 tracks - PharmaTech, Diagnostics 2.0, Care Coordination and Value-Based Care, and Remote Patient Monitoring and Smart Devices. Slots are going fast so we encourage all startups - particularly those interested to apply in the PharmaTech and Diagnostics tracks to apply immediately. Selected startups will get to pitch LIVE on stage in front of VC judges. Here's the agenda for the INVEST conference.
By Frank Vinluan Thursday, January 27, 2022 7:00 AM
Septerna has science from a Nobel laureate and technology that finds new ways to drug GPCRs, well-validated receptors targeted by about one-third of FDA-approved medicines. According to CEO Jeff Finer, the startup is kicking off a second golden age of GPCR drug development.
Six years in, the subtext of the scheduled reimbursements increase for 2022 is that CCM has proven to be an essential part of the care continuum, particularly in the wake of the Covid-19 pandemic, and has real value for patients, providers, and payers.
By Michael Schroeder Wednesday, January 26, 2022 6:33 PM
As virtual specialty care options continue to expand and access remains limited to dermatologists, Smart Health Innovation Lab announced this week that the platform, which allows people to do a full-body skin screening using a smartphone app, has joined the healthcare technology accelerator.
By Emma Bardin Wednesday, January 26, 2022 6:19 PM
Mantra Health, which provides digital mental health tools for university students, raised $22M in a Series A funding round to offer its evidence-based teletherapy and psychiatric services to patients with long term mental health issues.
By Arundhati Parmar Wednesday, January 26, 2022 4:37 PM
Barry Ticho explains the novel drug that the company is developing to tackle Dravet Syndrome as well as how the company's stock price decline isn't reflective of the true value of the therapy the company is hoping to commercialize.
Every company will eventually face an audit. Download this FREE general audit checklist to evaluate your organization and take proactive steps guaranteed to prepare you in order pass an audit when the time comes.
No comments